Erythromycin A 6,9-imino ether
CAS: 99290-97-8
Ref. 3D-FE146285
1mg | 248,00 € | ||
2mg | 364,00 € | ||
5mg | 517,00 € | ||
10mg | 801,00 € | ||
25mg | 1.392,00 € |
Informação sobre produto
- (1Z,3R,4R,5S,6R,9R,10S,11S,12R,13R,15R)-10-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-6-ethyl-4,5-dihydroxy-3,5,9,11,13,15-hexamethyl-12-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-7,16-dioxa-2-azabicyclo[11.2.1]hexadec-1-en-8-one
- 7,16-Dioxa-2-azabicyclo[11.2.1]hexadec-1-en-8-one, 10-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-6-ethyl-4,5-dihydroxy-3,5,9,11,13,15-hexamethyl-12-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-, [3R-(3R*,4R*,5S*,6R*,9R*,10S*,11S*,12R*,13R*,15R*)]-
- 7,16-Dioxa-2-azabicyclo[11.2.1]hexadec-1-en-8-one, 10-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-6-ethyl-4,5-dihydroxy-3,5,9,11,13,15-hexamethyl-12-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-, (1Z,3R,4R,5S,6R,9R,10S,11S,12R,13R,15R)-
Erythromycin is a macrolide antibiotic that inhibits bacterial growth by binding to the 50S ribosomal subunit. It has been shown to have antibacterial activity against both staphylococci and streptococci. Erythromycin binds to the 23S ribosomal RNA, which prevents protein synthesis and cell division. The drug is used for the treatment of infections caused by bacteria susceptible to erythromycin, such as Group P2 (Streptococcus pneumoniae) and Group A (Staphylococcus aureus). Erythromycin also inhibits the biosynthesis of macrolactones, which are antibiotics related to erythromycin. These compounds are found in Streptomyces spp., Actinomycetes spp., and Mycobacterium smegmatis.
Propriedades químicas
Consulta técnica sobre: 3D-FE146285 Erythromycin A 6,9-imino ether
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.